| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.57M | $67.11M | - | |
| COO | 422.8K | $11.03M | - | |
| CFO | 212.2K | $5.54M | - | |
| Dir | 135.2K | $3.53M | - | |
| Dir | 51.1K | $1.33M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 25, 2018 | Ligand Pharmaceuticals Inc | 10% Owner | Sell | 262,881 | $19.15 | $5,034,250.01 | -4.2% | |
| May 31, 2018 | Michael Morneau | VP, Finance and Administration | Sell | 21,551 | $9.25 | $199,346.75 | -18.6% | |
| May 31, 2018 | J Matthew Singleton75 | Director | Buy | 9,500 | $9.82 | $93,260.55 | New | |
| May 29, 2018 | Charles A Rowland Jr.49 | Director | Buy | 30,000 | $5.16 | $154,800.00 | New | |
| May 29, 2018 | Stephen W Webster | Director | Buy | 8,000 | $5.21 | $41,712.00 | New | |
| May 29, 2018 | Lawson MacArtney | Director | Buy | 47,965 | $5.22 | $250,329.34 | New | |
| Nov 15, 2016 | Matthew W Foehr71 | Director | Buy | 13,000 | $1.21 | $15,678.00 | +49.5% | |
| Apr 13, 2016 | Matthew W Foehr71 | Director | Buy | 20,000 | $1.24 | $24,800.00 | +320.0% | |
| May 4, 2015 | Matthew W Foehr71 | Director | Buy | 6,250 | $8.00 | $50,000.00 | New |